TY - JOUR
T1 - Predictive Capacity of Oxygen Delivery During Cardiopulmonary Bypass on Acute Kidney Injury
AU - Newland, Richard F.
AU - Baker, Robert A.
AU - Woodman, Richard J.
AU - Barnes, Mary B.
AU - Willcox, Timothy W.
AU - Australian and New Zealand Collaborative Perfusion Registry
PY - 2019/12
Y1 - 2019/12
N2 - Background: The randomized goal-directed perfusion trial confirmed retrospective findings that a goal-directed perfusion strategy to maintain oxygen delivery index (DO2i) during cardiopulmonary bypass greater than 280 mL/min/m2 reduces the incidence of acute kidney injury (AKI). We developed a predictive model for AKI using data from the Australian and New Zealand Collaborative Perfusion Registry to determine whether these findings could be validated in a real-world clinical setting and to identify an optimal DO2i threshold for predictive diagnostic accuracy. Methods: Data in 19,410 cardiopulmonary bypass procedures were randomly divided into training (n = 9705) and validation (n = 9705) datasets. Multivariate logistic regression was used to determine the best predictive models for AKI (RIFLE [renal Risk, Injury, Failure, Loss of renal function and End-stage renal disease] classification), incremental predictive value of minimum cardiopulmonary bypass DO2i, and optimal threshold. Results: Minimum DO2i was significantly associated with any AKI, AKI risk, and AKI injury or greater class in both datasets (validation dataset; any AKI odds ratio [OR], 0.993; 95% confidence interval [CI], 0.991-0.995; P < .001; AKI risk OR, 0.994; 95% CI, 0.992-0.996; P < .001, AKI injury or greater 0.993; 95% CI, 0.991-0.996; P < .001), representing on average a 7% increase in the likelihood of AKI for every 10-mL/min/m2 decrease in DO2i. Diagnostic accuracy was similar for both datasets, with an optimal DO2i threshold of 270 mL/min/m2. The odds of any AKI were increased by 52% in those below the threshold (OR, 1.52; 95% CI, 1.29-1.77; P < .001). Conclusions: This study confirms previous findings that minimum DO2i during cardiopulmonary bypass is independently associated with AKI, supporting previous findings in a broader-risk, multicenter cohort.
AB - Background: The randomized goal-directed perfusion trial confirmed retrospective findings that a goal-directed perfusion strategy to maintain oxygen delivery index (DO2i) during cardiopulmonary bypass greater than 280 mL/min/m2 reduces the incidence of acute kidney injury (AKI). We developed a predictive model for AKI using data from the Australian and New Zealand Collaborative Perfusion Registry to determine whether these findings could be validated in a real-world clinical setting and to identify an optimal DO2i threshold for predictive diagnostic accuracy. Methods: Data in 19,410 cardiopulmonary bypass procedures were randomly divided into training (n = 9705) and validation (n = 9705) datasets. Multivariate logistic regression was used to determine the best predictive models for AKI (RIFLE [renal Risk, Injury, Failure, Loss of renal function and End-stage renal disease] classification), incremental predictive value of minimum cardiopulmonary bypass DO2i, and optimal threshold. Results: Minimum DO2i was significantly associated with any AKI, AKI risk, and AKI injury or greater class in both datasets (validation dataset; any AKI odds ratio [OR], 0.993; 95% confidence interval [CI], 0.991-0.995; P < .001; AKI risk OR, 0.994; 95% CI, 0.992-0.996; P < .001, AKI injury or greater 0.993; 95% CI, 0.991-0.996; P < .001), representing on average a 7% increase in the likelihood of AKI for every 10-mL/min/m2 decrease in DO2i. Diagnostic accuracy was similar for both datasets, with an optimal DO2i threshold of 270 mL/min/m2. The odds of any AKI were increased by 52% in those below the threshold (OR, 1.52; 95% CI, 1.29-1.77; P < .001). Conclusions: This study confirms previous findings that minimum DO2i during cardiopulmonary bypass is independently associated with AKI, supporting previous findings in a broader-risk, multicenter cohort.
UR - http://www.scopus.com/inward/record.url?scp=85072616157&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2019.04.115
DO - 10.1016/j.athoracsur.2019.04.115
M3 - Article
C2 - 31238029
AN - SCOPUS:85072616157
SN - 0003-4975
VL - 108
SP - 1807
EP - 1814
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 6
ER -